FR2665834B1 - Composition pharmaceutique stabilisee par un donneur d'acide chlorhydrique, et sa preparation. - Google Patents

Composition pharmaceutique stabilisee par un donneur d'acide chlorhydrique, et sa preparation.

Info

Publication number
FR2665834B1
FR2665834B1 FR9109373A FR9109373A FR2665834B1 FR 2665834 B1 FR2665834 B1 FR 2665834B1 FR 9109373 A FR9109373 A FR 9109373A FR 9109373 A FR9109373 A FR 9109373A FR 2665834 B1 FR2665834 B1 FR 2665834B1
Authority
FR
France
Prior art keywords
donor
preparation
pharmaceutical composition
hydrochloric acid
composition stabilized
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9109373A
Other languages
English (en)
Other versions
FR2665834A1 (fr
Inventor
Bruce Allan Ross
Richard Victor Vivilecchia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Priority to FR9109373A priority Critical patent/FR2665834B1/fr
Publication of FR2665834A1 publication Critical patent/FR2665834A1/fr
Application granted granted Critical
Publication of FR2665834B1 publication Critical patent/FR2665834B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55Protease inhibitors
    • A61K38/556Angiotensin converting enzyme inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR9109373A 1991-07-24 1991-07-24 Composition pharmaceutique stabilisee par un donneur d'acide chlorhydrique, et sa preparation. Expired - Lifetime FR2665834B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR9109373A FR2665834B1 (fr) 1991-07-24 1991-07-24 Composition pharmaceutique stabilisee par un donneur d'acide chlorhydrique, et sa preparation.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9109373A FR2665834B1 (fr) 1991-07-24 1991-07-24 Composition pharmaceutique stabilisee par un donneur d'acide chlorhydrique, et sa preparation.

Publications (2)

Publication Number Publication Date
FR2665834A1 FR2665834A1 (fr) 1992-02-21
FR2665834B1 true FR2665834B1 (fr) 2001-02-23

Family

ID=9415492

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9109373A Expired - Lifetime FR2665834B1 (fr) 1991-07-24 1991-07-24 Composition pharmaceutique stabilisee par un donneur d'acide chlorhydrique, et sa preparation.

Country Status (1)

Country Link
FR (1) FR2665834B1 (fr)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU173823B (hu) * 1975-07-25 1979-08-28 Chinoin Gyogyszer Es Vegyeszet Sposob poluchenija stabil'nogo lechebnogo preparata dlja oral'noj dozirovki, kotoryj soderzhit proizvodnyj gomopirimidazola
US4442089A (en) * 1982-07-06 1984-04-10 E. R. Squibb & Sons, Inc. Method for treating glaucoma with topical or systemic ACE inhibitor compositions
US4900559A (en) * 1985-12-12 1990-02-13 Briston-Myers Company Stabilized enteric coated aspirin granules and process of preparation
US4743450A (en) * 1987-02-24 1988-05-10 Warner-Lambert Company Stabilized compositions
JP2603480B2 (ja) * 1987-08-05 1997-04-23 住友製薬株式会社 安定化されたアンスラサイクリン系製剤

Also Published As

Publication number Publication date
FR2665834A1 (fr) 1992-02-21

Similar Documents

Publication Publication Date Title
DK1155695T3 (da) Anvendelse af en 1,3-oxathiolannukleosid-analog til fremstillingen af et lægemiddel til specifik indgivelse
MX9205064A (es) Heterociclos condensados de 5 miembros, procedimientos para su preparacion y medicamentos que contienen estos compuestos.
IT1231434B (it) Composizione farmaceutica endovenosa e procedimento per la sua preparazione.
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
IT8621358A0 (it) Composizione farmaceutica adattivita' analgesica.
DE69015842D1 (de) Nicotinsäurederivate und diese enthaltende pharmazeutische Zusammensetzungen.
DK515489D0 (da) Dispergerbar laegemiddelformulering
NL192832B (nl) 1,8 gebrugde 6-halogeen-4-chinolon-3-carbonzuurderivaten en farmaceutisch preparaat dat een dergelijk derivaat bevat.
BE893193A (fr) Composition pharmaceutique contenant du 24-25-dihydroxy-cholecalciferol a titre d'ingredient actif
MX9203555A (es) Sistema intravenoso para administrar un agente benefico y/o farmaco.
NZ231353A (en) Pharmaceutical compositions comprising 3,5-dihydroxy-7-(1-acyloxyhexahydronaphth-8-yl)-heptanoic acid and lactone derivatives
MA22443A1 (fr) Procede de preparation d'une composition pharmaceutique .
IT8919279A0 (it) Composizioni farmaceutiche contenenti un estratto vegetale e procedimento per la loro preparazione.
ITTO920303A0 (it) "composizione farmaceutica antiinfiammatoria"
SE8204873L (sv) Farmaceutiska preparat, innefattande humant insulin och human c-peptid
DE68902300T2 (de) Pharmazeutische loesung enthaltend salbutamol und cromoglycinsaeure.
ITMI911880A1 (it) Metodo per la preparazione di forme farmaceutiche orali a rilascio prolungato contenenti sostanze attive a solubilita' dipendente dal valore di ph.
PT101238A (pt) Composicoes a base de 1-(2'-desoxi-2'-fluoro-beta-d-arabinofuranosil)-5-iodo-uracilo para tratamento de infeccao e doenca causada pelo virus da hepatite b, sua preparacao e uso
DE3576505D1 (de) 3,4-dihydrobenzopyranverbindungen und diese enthaltende pharmazeutische zusammenstellungen.
FR2665834B1 (fr) Composition pharmaceutique stabilisee par un donneur d'acide chlorhydrique, et sa preparation.
FR2660195B1 (fr) Composition pharmaceutique a macher, antiinflammatoire et/ou analgesique.
FI870732A (fi) Glycero-3(2)-fosfo-l-serinderivat och deras salter, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska preparat.
FR2677250B1 (fr) Compositions pharmaceutiques contenant de l'adenosine-5-triphosphate disodique.
ES2062313T3 (es) 13-bromo- y 13,14-dibromo-ergolinas, a su preparacion y a su utilizacion en medicamentos.
IT8619288A0 (it) Formulazioni farmaceutiche iniettabili di principi attivi adattivita' anestetica generale.

Legal Events

Date Code Title Description
TP Transmission of property